Calculating the codeine cost

A new report has revealed proposed codeine rescheduling will cost the federal government $316m annually.

The Pharmacy Guild of Australia-sponsored report, produced by Cadence Economics, analysed the fiscal impacts (and related issues) of moving all codeine-containing medicines to prescription only (S4).

The report reveals that - at a conservative estimate - 53% of patients would visit a GP to obtain codeine-based analgesics. The estimate does not include the MBS cost of any increased GP visits by patients who are no longer able to access codeine containing cough and cold